+ Watch JNJ
on My Watchlist
A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.
J&J is not a company that has experienced significant growth (in terms of stock price) over the past few years. It has mainly sustained its self on it's brand name recognition that has been significantly tarnished in 2010 due to several recalls. Fantastic as a dividend delivering stock, but not one necessarily positioned for significant growth... at least for another year or so.
JNJ has an enormous product line, matching its enormous market cap. For it to have a number of recalls is not a "thumbs down" to me. If you want to see bad recall news, look at the largest maker of pacemakers, Medtronic. Often, it's just a software update that can be downloaded by transducer; other times it's a hardware warning that could result in a stopped heart. A few cracked syringes, as in a very recent JNJ recall, is hardly worth wringing hands over.And dividends aren't too bad.I certainly cannot argue with any of your other observations.
Thanks for the good feedback. I should probably qualify the type of growth I was thinking about. J&J is not a company that is poised for significant "organic" growth from the company its self. This tends to be slower and more conservative with the company. As I continue to watch them, they have experienced growth (and subsequent increase in stock price) through acquisition of various smaller companies that are ripe for the picking due to the recent economic downturn. Perhaps that's why my "thumbs down" pick isn't paying off at the moment... you live you learn. :-)
"you live and you learn" you know a good investor when he/she says that, not afraid to admit mistakes, and I'm sure does well when he/she succeeds :)
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions